Literature DB >> 12457378

Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.

Esther Gómez-Gil1, Cristóbal Gastó, Maribel Díaz-Ricart, Marta Carretero, Manel Salamero, Rosa Catalán, Ginés Escolar.   

Abstract

BACKGROUND: Studies of the 5-HT(2A) receptor subtype in major depression have focused on the density of these receptors in neuronal cells and platelets, showing an up-regulation secondary to a deficit in serotonergic activity in major depression. However, their functional state has often been disregarded. The aim of the study was to investigate whether depressed patients show abnormalities in the function of the 5-HT(2A) receptor pathway in platelets.
METHOD: The percentage of serotonin-amplified platelet aggregation to adenosine diphosphate (ADP) was assessed in 30 untreated patients with major depressive disorder and in 15 controls. Since 5-HT(2A) platelet receptors mediate the serotonin-induced platelet aggregation response, this index was used as a measure of the functional status of the platelet 5-HT(2A) receptor pathway.
RESULTS: There was no significant difference in the percentage of serotonin-amplified platelet aggregation to ADP between depressed patients and controls. No correlation with the severity of depression, as assessed by the Hamilton scale, was found.
CONCLUSION: The results showed no consistent changes in the platelet aggregating responses to serotonin in the depressed patients. Therefore this study does not support the hypothesis of an alteration of the functional status of platelet 5-HT(2A) receptors in major depression. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457378     DOI: 10.1002/hup.429

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  4 in total

Review 1.  Platelets and depression in cardiovascular disease: A brief review of the current literature.

Authors:  Marlene S Williams
Journal:  World J Psychiatry       Date:  2012-12-22

2.  Emotional Blunting, Cognitive Impairment, Bone Fractures, and Bleeding as Possible Side Effects of Long-Term Use of SSRIs.

Authors:  Donatella Marazziti; Federico Mucci; Beniamino Tripodi; Manuel Glauco Carbone; Alessia Muscarella; Valentina Falaschi; Stefano Baroni
Journal:  Clin Neuropsychiatry       Date:  2019-04

3.  Serotonin-Affecting Antidepressant Use in Relation to Platelet Reactivity.

Authors:  Joseph Grech; Melissa Victoria Chan; Chinedu Ochin; Amber Lachapelle; Florian Thibord; Zoe Schneider; Bongani Brian Nkambule; Paul Charles John Armstrong; Catherine Wallace de Melendez; Katherine L Tucker; Mahdi Garelnabi; Timothy David Warner; Ming-Huei Chen; Andrew Danner Johnson
Journal:  Clin Pharmacol Ther       Date:  2022-01-10       Impact factor: 6.903

4.  Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study.

Authors:  Raymond Noordam; Nikkie Aarts; Maarten J G Leening; Henning Tiemeier; Oscar H Franco; Albert Hofman; Bruno H Stricker; Loes E Visser
Journal:  Eur J Clin Pharmacol       Date:  2015-11-07       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.